MX9705077A - Agente para la profilaxis y tratamiento del trastorno de la funcion visual. - Google Patents
Agente para la profilaxis y tratamiento del trastorno de la funcion visual.Info
- Publication number
- MX9705077A MX9705077A MX9705077A MX9705077A MX9705077A MX 9705077 A MX9705077 A MX 9705077A MX 9705077 A MX9705077 A MX 9705077A MX 9705077 A MX9705077 A MX 9705077A MX 9705077 A MX9705077 A MX 9705077A
- Authority
- MX
- Mexico
- Prior art keywords
- asthenopia
- agent
- prophylaxis
- treatment
- formula
- Prior art date
Links
- 208000003464 asthenopia Diseases 0.000 title abstract 5
- 238000011321 prophylaxis Methods 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un agente para la profilaxis y tratamiento de trastorno de la funcion visual, que comprende un compuesto de la formula [1]: en donde el anillo A es opcionalmente substituido, R1 es un hidrogeno o un amino opcionalmente protegido, y R2 es un grupo capaz de liberar un proton, o una sal del mismo; el agente para la profilaxis y tratamiento de trastorno de la funcion visual de la presente invencion tiene efecto preventivo y terapéutico superior sobre la astenopía, y muestra supresion de alargamiento axial, supresion de degradacion de funciones retinales y accion de recuperacion de funcion retinal; por lo tanto, el agente se puede usar ventajosamente como un agente clínicamente aplicable para la profilaxis y tratamiento de trastorno de la funcion visual.
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17693396 | 1996-07-05 | ||
| JP8-176933/1996 | 1996-07-05 | ||
| JP8-176933 | 1996-07-05 | ||
| JP21394196 | 1996-08-13 | ||
| JP8-213941/1996 | 1996-08-13 | ||
| JP8-213941 | 1996-08-13 | ||
| JP31403396 | 1996-11-25 | ||
| JP8-314033 | 1996-11-25 | ||
| JP8-314033-1996 | 1996-11-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9705077A true MX9705077A (es) | 1998-05-31 |
| MXPA97005077A MXPA97005077A (es) | 1998-10-23 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| ID17647A (id) | 1998-01-15 |
| KR980008226A (ko) | 1998-04-30 |
| EP0819431A1 (en) | 1998-01-21 |
| CN1172644A (zh) | 1998-02-11 |
| HU9701150D0 (en) | 1997-09-29 |
| CA2209581A1 (en) | 1998-01-05 |
| HUP9701150A2 (hu) | 1999-02-01 |
| BR9703874A (pt) | 1998-09-01 |
| US5952338A (en) | 1999-09-14 |
| AU2843397A (en) | 1998-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9800411A (es) | Compuestos quimicos. | |
| AU4950993A (en) | Combination of germicidal agents | |
| NZ332762A (en) | Isobutylgaba and its derivatives for the treatment of pain | |
| TW369536B (en) | Phosphonate nucleotide compounds | |
| GB9514473D0 (en) | Chemical compounds | |
| NZ330973A (en) | Azolobenzazepine derivatives as neurologically active agents | |
| NZ502988A (en) | 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza | |
| CA2154572A1 (fr) | Application du riluzole dans le traitement du neuro-sida | |
| AU2001266575A1 (en) | Chemical compounds | |
| GB9107827D0 (en) | New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same | |
| AU1367497A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma | |
| MX9708452A (es) | Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma. | |
| NO983178L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer | |
| UA37311C2 (uk) | Засіб для лікування статевої дисфункції і фармацевтичний препарат | |
| ES8401067A1 (es) | Procedimiento analogo para preparar un derivado de tropil benzoato. | |
| AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| MY124078A (en) | Eletriptan hydrobromide monohydrate | |
| DE3476847D1 (en) | A remedial or prophylactic agent for the treatment of seizures | |
| UA41880C2 (uk) | Серотонінергічні похідні ерголіну і фармацевтична композиція | |
| MX9705077A (es) | Agente para la profilaxis y tratamiento del trastorno de la funcion visual. | |
| NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
| HUT75529A (en) | Use of dimeticone for treating constipation | |
| AU4944899A (en) | New pharmaceutically active compounds | |
| AU2287499A (en) | Azetidinecarboxamide derivatives for treating cns disorders | |
| MX9701606A (es) | Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno. |